Vijay Sankaran

Vijay Sankaran is a physician at Dana-Farber Cancer Institute, specializing in hematology and oncology. He has contributed significantly to the understanding and treatment of blood cancers, including acute myeloid leukemia (AML). His insights on the sudden emergence of AML and the challenges of treatment highlight the complexities of managing this aggressive disease. Sankaran has been vocal about the need for increased research funding to improve outcomes for cancer patients, emphasizing that even those with access to top-tier care can face dire prognoses.